Ironwood Pharmaceuticals Inc (IRWD)

Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 2.4% - MarketBeat

MarketBeat

Ironwood Pharmaceuticals (NASDAQ:IRWD) PT Lowered to $14.00 at Craig Hallum - Defense World

Defense World

The 3.7% return this week takes Ironwood Pharmaceuticals' (NASDAQ:IRWD) shareholders three-year gains to 25% - Yahoo Canada Shine On

Yahoo Canada Shine On

US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results - Yahoo Finance

Yahoo Finance

Objective long/short (IRWD) Report - Stock Traders Daily

Stock Traders Daily

Ironwood Pharmaceuticals (NASDAQ:IRWD) Releases Quarterly Earnings Results, Misses Expectations By $0.20 EPS - MarketBeat

MarketBeat

Craig Hallum Lowers Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target to $14.00 - MarketBeat

MarketBeat

Ironwood (IRWD), AbbVie Get FDA Nod for Linzess Label Expansion - Yahoo Singapore News

Yahoo Singapore News

Earnings call: Ironwood Pharmaceuticals reports robust Q1 growth - Investing.com

Investing.com

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates - Yahoo Finance Australia

Yahoo Finance Australia

Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023) - Simply Wall St

Simply Wall St

Ironwood: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Piper Sandler Maintains Ironwood Pharmaceuticals Inc - (IRWD) Overweight Recommendation - MSN

MSN

Ironwood Pharmaceuticals Reports First Quarter 2024 Results - citybiz

citybiz

Opioid Induced Constipation Drugs Market 2023-2030 Insight View - NEWS CHANNEL NEBRASKA

NEWS CHANNEL NEBRASKA

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Down to $8.12 - MarketBeat

MarketBeat

Ironwood Pharmaceuticals Becomes Oversold (IRWD) - Nasdaq

Nasdaq

Ironwood Pharmaceuticals Reports First Quarter 2024 Results - 09.05.2024 - wallstreet:online

wallstreet:online

Ironwood Pharmaceuticals Reports First Quarter 2024 Results - Business Wire

Business Wire

Ironwood Pharmaceuticals Reports First Quarter 2024 Results - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates - Yahoo Movies UK

Yahoo Movies UK

Ironwood Pharmaceuticals (IRWD) Scheduled to Post Quarterly Earnings on Thursday - Defense World

Defense World

Ironwood to End IW-3718 Development After Study Failure - Yahoo Movies Canada

Yahoo Movies Canada

Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference - Business Wire

Business Wire

H.C. Wainwright Sticks to Their Hold Rating for Ironwood Pharma - Yahoo Movies UK

Yahoo Movies UK

LSV Asset Management Decreases Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

MarketBeat

New York State Common Retirement Fund Acquires 8740 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Defense World

FY2025 EPS Estimates for Ironwood Pharmaceuticals, Inc. Raised by Analyst (NASDAQ:IRWD) - MarketBeat

MarketBeat

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline - Zacks Investment Research

Zacks Investment Research

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline

Zacks Investment Research

Ironwood Pharmaceuticals (IRWD) to Release Earnings on Thursday - MarketBeat

MarketBeat

Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal ... - Business Wire

Business Wire

Daiwa Securities Group Inc. Purchases 1900 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Defense World

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call - Business Wire

Business Wire

Investors in Ironwood Pharmaceuticals (NASDAQ:IRWD) from five years ago are still down 29%, even after 8.6% gain this past week - Simply Wall St

Simply Wall St

How To Trade (IRWD) - Stock Traders Daily

Stock Traders Daily

5 Best Low Price Pharma Stocks To Invest In - Insider Monkey

Insider Monkey

Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in ... - Business Wire

Business Wire

OPKO Health (OPK) And Entera Bio Announce Data for GLP-2

Zacks Investment Research

Ironwood Pharmaceuticals (NASDAQ:IRWD): Analysts Stay Bullish Despite Recent Stock Plunge - TipRanks.com - TipRanks

TipRanks

Ironwood Pharmaceuticals (NASDAQ:IRWD): Analysts Stay Bullish Despite Recent Stock Plunge - TipRanks.com - TipRanks

TipRanks

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March

Benzinga

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March - Markets Insider

Markets Insider

Clinical report: Akero's efruxifermin shows deepening treatment effect at 96 weeks - BioCentury

BioCentury

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Nasdaq Gains 100 Points Following PCE Data

Benzinga

Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge

Benzinga

Ironwood's apraglutide wins in short bowel but CIC questioned - BioWorld Online

BioWorld Online

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference - Business Wire

Business Wire